125 related articles for article (PubMed ID: 10462984)
1. [Polycystic ovary syndrome in adolescent gynecology].
Micinski P; Kuczera B; Sirko I; Poreba R
Ginekol Pol; 1999 May; 70(5):370-3. PubMed ID: 10462984
[TBL] [Abstract][Full Text] [Related]
2. [Preliminary study on the value of ratio of serum luteinizing hormone/follicle-stimulating hormone in diagnosis of polycystic ovarian syndrome among women with polycystic ovary].
Ma CS; Lin Y; Zhang CH; Xu H; Li YF; Zhang SC; Tan Y; Quan S; Xing FQ
Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):177-80. PubMed ID: 21575449
[TBL] [Abstract][Full Text] [Related]
3. Free testosterone, luteinizing hormone/follicle stimulating hormone ratio and pelvic sonography in relation to skin manifestations in patients with polycystic ovary syndrome.
Sharquie KE; Al-Bayatti AA; Al-Ajeel AI; Al-Bahar AJ; Al-Nuaimy AA
Saudi Med J; 2007 Jul; 28(7):1039-43. PubMed ID: 17603706
[TBL] [Abstract][Full Text] [Related]
4. Menstrual irregularity in the first postmenarchal years: an early clinical sign of polycystic ovary syndrome in adolescence.
Avvad CK; Holeuwerger R; Silva VC; Bordallo MA; Breitenbach MM
Gynecol Endocrinol; 2001 Jun; 15(3):170-7. PubMed ID: 11447727
[TBL] [Abstract][Full Text] [Related]
5. Polycystic ovary disease in two patients with Briquet's disorder.
Orenstein H; Raskind MA
Am J Psychiatry; 1983 Sep; 140(9):1202-4. PubMed ID: 6412573
[TBL] [Abstract][Full Text] [Related]
6. Endocrinological meaning of hyperandrogenism in patients with polycystic ovary.
Takahashi K; Eda Y; Kusakari M; Yoshino K; Kitao M
Gynecol Obstet Invest; 1991; 31(1):46-50. PubMed ID: 2010114
[TBL] [Abstract][Full Text] [Related]
7. [Effect of bromocryptin in polycystic ovary syndrome].
Fuhrer J; Cheviakoff S; Rubio V
Rev Chil Obstet Ginecol; 1989; 54(6):364-9; discussion 369-70. PubMed ID: 2485372
[TBL] [Abstract][Full Text] [Related]
8. Elevated bioactive luteinizing hormone in women with the polycystic ovary syndrome.
Lobo RA; Kletzky OA; Campeau JD; diZerega GS
Fertil Steril; 1983 May; 39(5):674-8. PubMed ID: 6220924
[TBL] [Abstract][Full Text] [Related]
9. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease.
Fauser BC; Pache TD; Lamberts SW; Hop WC; de Jong FH; Dahl KD
J Clin Endocrinol Metab; 1991 Oct; 73(4):811-7. PubMed ID: 1909705
[TBL] [Abstract][Full Text] [Related]
10. Hyperprolactinaemia in polycystic ovary syndrome.
Lunde O
Ann Chir Gynaecol; 1981; 70(4):197-201. PubMed ID: 6797343
[TBL] [Abstract][Full Text] [Related]
11. Synthetic luteinizing hormone-releasing hormone: its use in the differential diagnosis of secondary oligo-amenorrhea.
Patton WC; Thompson IE; Berger MJ; Chong AP; Taymor ML
Obstet Gynecol; 1974 Dec; 44(6):823-9. PubMed ID: 4612420
[No Abstract] [Full Text] [Related]
12. Relevance of the determination of ovarian volume in adolescent girls with menstrual disorders.
Herter LD; Magalháes JA; Spritzer PM
J Clin Ultrasound; 1996 Jun; 24(5):243-8. PubMed ID: 8723512
[TBL] [Abstract][Full Text] [Related]
13. Clinical, endocrinologic, and ultrasonographic features of polycystic ovary syndrome in Singaporean adolescents.
Dramusic V; Goh VH; Rajan U; Wong YC; Ratnam SS
J Pediatr Adolesc Gynecol; 1997 Aug; 10(3):125-32. PubMed ID: 9288656
[TBL] [Abstract][Full Text] [Related]
14. Hormone profile & polycystic ovaries in acne vulgaris.
Jebraili R; Kaur S; Kanwar AJ; Kataria S; Dash RJ
Indian J Med Res; 1994 Aug; 100():73-6. PubMed ID: 7927560
[TBL] [Abstract][Full Text] [Related]
15. [Ovarian hyperandrogenism in adolescent girls with menstrual disorders].
Małecka-Tendera E; Zachurzok A; Wrześniewski N; Kurkowska M
Ginekol Pol; 2002 Feb; 73(2):93-101. PubMed ID: 12001778
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
Rebar R; Judd HL; Yen SS; Rakoff J; Vandenberg G; Naftolin F
J Clin Invest; 1976 May; 57(5):1320-9. PubMed ID: 770505
[TBL] [Abstract][Full Text] [Related]
17. Body mass index and gonadotropin hormones (LH & FSH) associate with clinical symptoms among women with polycystic ovary syndrome.
Esmaeilzadeh S; Andarieh MG; Ghadimi R; Delavar MA
Glob J Health Sci; 2014 Sep; 7(2):101-6. PubMed ID: 25716399
[TBL] [Abstract][Full Text] [Related]
18. Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women.
Chae SJ; Kim JJ; Choi YM; Hwang KR; Jee BC; Ku SY; Suh CS; Kim SH; Kim JG; Moon SY
Hum Reprod; 2008 Aug; 23(8):1924-31. PubMed ID: 18579512
[TBL] [Abstract][Full Text] [Related]
19. [Different types of menstrual cycle and their significance in Chinese women diagnosed with polycystic ovary syndrome according to the Rotterdam consensus criteria].
Xu XH; Tan YC; Shi YH; Wang B; Ju XQ; Zheng QM; Hao CF; Chen ZJ
Zhonghua Yi Xue Za Zhi; 2009 Oct; 89(37):2604-6. PubMed ID: 20137675
[TBL] [Abstract][Full Text] [Related]
20. Is the polycystic ovary a cause of infertility in the ovulatory woman?
Eden JA; Place J; Carter GD; Alaghband-Zadeh J; Pawson M
Clin Endocrinol (Oxf); 1989 Jan; 30(1):77-82. PubMed ID: 2505956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
